B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP)

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Schernhammer, Eva S ^a,b,c   Giovannucci, Edward ^c   Baba, Yoshifumi ^d   Fuchs, Charles S ^a,d   Ogino, Shuji ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; FOLIC ACID; METHIONINE; PYRIDOXINE; VITAMIN B GROUP; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BRAF PROTEIN, HUMAN; CACNA1G PROTEIN, HUMAN; CALCIUM CHANNEL T TYPE; CELL CYCLE PROTEIN; CHFR PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HIC1 PROTEIN, HUMAN; IGF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MLH1 PROTEIN, HUMAN; NERVE PROTEIN; NEUROG1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RETINOIC ACID BINDING PROTEIN I, CELLULAR; RETINOIC ACID RECEPTOR; RUNX3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SOCS1 PROTEIN, HUMAN; SOMATOMEDIN B; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR RUNX3; TUMOR PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CARBON METABOLISM; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; CPG ISLAND METHYLATOR PHENOTYPE; DNA METHYLATION; FEMALE; GENE MUTATION; HUMAN; NUTRIENT; PHENOTYPE; PROSPECTIVE STUDY; RISK ASSESSMENT; VITAMIN INTAKE; COLON TUMOR; DRUG EFFECT; GENETICS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; RISK FACTOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM CHANNELS, T-TYPE; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; FOLIC ACID; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KRUPPEL-LIKE TRANSCRIPTION FACTORS; METHIONINE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; QUESTIONNAIRES; RECEPTORS, RETINOIC ACID; RISK FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 79959591185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021102     Document Type: Article

References (64)

1. Jones PA, Baylin SB, (2007) The epigenomics of cancer. Cell 128: 683-692.
2. Feinberg AP, Ohlsson R, Henikoff S, (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33.
3. Gosden RG, Feinberg AP, (2007) Genetics and epigenetics-nature's pen-and-pencil set. N Engl J Med 356: 731-733.
4. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
5. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
6. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al. (2005) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837-845.
7. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, et al. (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 3: e3698.
8. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, et al. (2008) Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 68: 8541-8546.
9. Ogino S, Goel A, (2008) Molecular classification and correlates in colorectal cancer. J Mol Diagn 10: 13-27.
10. Minoo P, Moyer MP, Jass JR, (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212: 124-133.
11. Hinoue T, Weisenberger DJ, Pan F, Campan M, Kim M, et al. (2009) Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One 4: e8357.
12. Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, et al. (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21: 3110-3122.
13. Nosho K, Shima K, Irahara N, Kure S, Baba Y, et al. (2009) DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 15: 3663-3671.
14. Karpinski P, Myszka A, Ramsey D, Misiak B, Gil J, et al. (2010) Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiol 34: 338-344.
15. Kim YI, (2004) Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 44: 10-25.
16. Giovannucci E, (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132: 2350S-2355S.
17. Harnack L, Jacobs DR Jr, Nicodemus K, Lazovich D, Anderson K, et al. (2002) Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer 43: 152-158.
18. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al. (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87: 265-273.
19. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, et al. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102.
20. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, et al. (2010) Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut 59: 794-799.
21. Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, et al. (2010) Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 3: 1552-1564.
22. de Vogel S, Bongaerts BW, Wouters KA, Kester AD, Schouten LJ, et al. (2008) Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis 29: 1765-1773.
23. Slattery ML, Curtin K, Wolff RK, Herrick JS, Caan BJ, et al. (2010) Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control 21: 1237-1245.
24. Van Guelpen B, Dahlin AM, Hultdin J, Eklof V, Johansson I, et al. (2010) One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes Control 21: 557-566.
25. Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, et al. (2011) Nutrients in Folate-Mediated, One-Carbon Metabolism and the Risk of Rectal Tumors in Men and Women. Nutr Cancer 63: 357-366.
26. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, et al. (1998) Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129: 517-524.
27. Chen J, Giovannucci E, Hankinson SE, Ma J, Willett WC, et al. (1998) A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19: 2129-2132.
28. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, et al. (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65.
29. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, et al. (1993) Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85: 875-884.
30. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, et al. (1988) The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127: 188-199.
31. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, et al. (1987) Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316: 1174-1180.
32. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, et al. (1984) Test of the National Death Index. Am J Epidemiol 119: 837-839.
33. Chan AT, Ogino S, Fuchs CS, (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356: 2131-2142.
34. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, et al. (2005) Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 7: 413-421.
35. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS, (2006) CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588.
36. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
37. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, et al. (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8: 209-217.
38. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, et al. (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9: 305-314.
39. Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, et al. (2006) CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55: 1000-1006.
40. Lunn M, McNeil D, (1995) Applying Cox regression to competing risks. Biometrics 51: 524-532.
41. Glynn RJ, Rosner B, (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162: 975-982.
42. Schernhammer ES, Ogino S, Fuchs CS, (2008) Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology 135: 770-780.
43. Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, et al. (2005) Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 97: 684-692.
44. Fuchs CS, Willett WC, Colditz GA, Hunter DJ, Stampfer MJ, et al. (2002) The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev 11: 227-234.
45. Ogino S, Chan AT, Fuchs CS, Giovannucci E, (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60: 397-411.
46. Suzuki H, Toyota M, Sato H, Sonoda T, Sakauchi F, et al. (2006) Roles and causes of abnormal DNA methylation in gastrointestinal cancers. Asian Pac J Cancer Prev 7: 177-185.
47. Oyama K, Kawakami K, Maeda K, Ishiguro K, Watanabe G, (2004) The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res 24: 649-654.
48. Hazra A, Fuchs CS, Kawasaki T, Kirkner GJ, Hunter DJ, et al. (2010) Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer. Cancer Causes Control 21: 331-345.
49. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, et al. (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28: 1672-1679.
50. de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, et al. (2011) Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer. Cancer Causes Control 22: 1-12.
51. Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, et al. (2007) Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120: 656-663.
52. Kawakami K, Ooyama A, Ruszkiewicz A, Jin M, Watanabe G, et al. (2008) Low expression of gamma-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype. Br J Cancer 98: 1555-1561.
53. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, et al. (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63: 3133-3137.
54. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, et al. (2008) Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 40: 904-908.
55. Schilling E, El Chartouni C, Rehli M, (2009) Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res 19: 2028-2035.
56. Zhang Y, Rohde C, Reinhardt R, Voelcker-Rehage C, Jeltsch A, (2009) Non-imprinted allele-specific DNA methylation on human autosomes. Genome Biol 10: R138.
57. Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, et al. (2007) Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer 120: 1684-1688.
58. Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, et al. (2008) The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer 47: 835-844.
59. Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, et al. (2007) MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst 99: 463-474.
60. Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, et al. (2007) MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis 28: 1985-1990.
61. Candiloro IL, Dobrovic A, (2009) Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res (Phila Pa) 2: 862-867.
62. Hawkins NJ, Lee JH, Wong JJ, Kwok CT, Ward RL, et al. (2009) MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol 22: 1588-1599.
63. Food and Drug Administration (1996) Food standards: amendment of standards of identity ro enriched grain products to require addition of folic acid. Final rule. Fed Regist. 21 CFR Parts 136, 137, and 139 21 CFR Parts 136, 137, and 139 pp. 8797-8807.
64. Schernhammer ES, Giovannuccci E, Fuchs CS, Ogino S, (2008) A prospective study of dietary folate and vitamin B and colon cancer according to microsatellite instability and KRAS mutational status. Cancer Epidemiol Biomarkers Prev 17: 2895-2898.